Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Colorado, Denver
Oslo University Hospital
Oslo University Hospital
Northwestern University
City of Hope Medical Center
Institut Bergonié
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Columbia University
Fox Chase Cancer Center
Sarcoma Oncology Research Center, LLC
Memorial Sloan Kettering Cancer Center
Pfizer
North Eastern German Society of Gynaecological Oncology
Washington University School of Medicine
Philogen S.p.A.
pharmaand GmbH
Ohio State University Comprehensive Cancer Center
Canadian Cancer Trials Group
Massachusetts General Hospital
Brown University
Italian Sarcoma Group
OHSU Knight Cancer Institute
Brown University
Maria Sklodowska-Curie National Research Institute of Oncology
UNICANCER
M.D. Anderson Cancer Center
Eli Lilly and Company
National Cancer Institute (NCI)
Mario Negri Institute for Pharmacological Research
National Cancer Institute (NCI)
Massachusetts General Hospital
Dana-Farber Cancer Institute
Novartis
UNICANCER
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
Sarcoma Alliance for Research through Collaboration
Oncolytics Biotech
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)